Biotech · Private company
Tetra Discovery Partners
Track this companyFree. Adds Tetra Discovery Partners to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- BPN14770/ zatolmilastPhase 3 · Fragile X SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- zatolmilastPhase 3 · Fragile X SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Zatolmilast/ BPN14770Phase 3 · Fragile X SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- BPN14770Phase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BPN14770Phase 2 · Fragile X SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- BPN14770, T2310Phase 1 · To Determine Brain Target Occupancy of BPN14770ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- An Open-Label Extension Study of BPN14770 in Subjects With Fragile X SyndromePHASE3 · ACTIVE_NOT_RECRUITING · started Nov 1, 2022ClinicalTrials.gov NCT05367960 · fetched Nov 12, 2026
- A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X SyndromePHASE3 · COMPLETED · started Nov 1, 2022ClinicalTrials.gov NCT05358886 · fetched Nov 12, 2026
- A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X SyndromePHASE2_PHASE3 · COMPLETED · started Mar 29, 2022ClinicalTrials.gov NCT05163808 · fetched Nov 12, 2026
- A Phase 1, Open-Label, PET Study of T2310 & BPN14770PHASE1 · WITHDRAWN · started Jan 10, 2020ClinicalTrials.gov NCT04044781 · fetched Nov 12, 2026
- Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's SubjectsPHASE2 · COMPLETED · started Apr 30, 2019ClinicalTrials.gov NCT03817684 · fetched Nov 12, 2026
- A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X SyndromePHASE2 · COMPLETED · started Jul 9, 2018ClinicalTrials.gov NCT03569631 · fetched Nov 12, 2026